Filing Flows › Comparisons › TRDA vs TXMD
Entrada Therapeutics vs TherapeuticsMD: TRDA and TXMD compared
Entrada Therapeutics is the larger company: $905K of revenue in its latest quarter (Q3 2026) against $869K for TherapeuticsMD (Q2 2026). TherapeuticsMD is growing faster (-9% against -44% a year earlier).
Where the money goes: TRDA and TXMD
Entrada Therapeutics (TRDA) · Q3 2026
Entrada Therapeutics, Q3 2026: revenue $905K (-44% year over year), net loss $39.7M, operating cash flow −$30.0M. The chart follows the revenue to costs, profit and cash.
TherapeuticsMD (TXMD) · Q2 2026
TherapeuticsMD, Q2 2026: revenue $869K (-9% year over year), operating margin -93.9%, net earnings $155K, operating cash flow $779K. The chart follows the revenue to costs, profit and cash.
| Entrada Therapeutics (TRDA) | TherapeuticsMD (TXMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $905K | $869K |
| Revenue growth, Y/Y | -44% | -9% |
| Operating margin | n/m | -93.9% |
| Net earnings | −$39.7M | $155K |
| Net margin | — | 17.8% |
| Operating cash flow | −$30.0M | $779K |
Questions
Which is bigger, Entrada Therapeutics or TherapeuticsMD?
Entrada Therapeutics is the larger company: $905K of revenue in its latest quarter (Q3 2026) against $869K for TherapeuticsMD (Q2 2026).
Is Entrada Therapeutics or TherapeuticsMD growing faster?
TherapeuticsMD is growing faster (-9% against -44% a year earlier).
More: Entrada Therapeutics earnings · how Entrada Therapeutics makes money · TherapeuticsMD earnings · how TherapeuticsMD makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.